Delusional parasitosis: six-year experience with 23 consecutive cases at an academic medical center  by Boggild, Andrea K. et al.
International Journal of Infectious Diseases 14 (2010) e317–e321Delusional parasitosis: six-year experience with 23 consecutive cases at an
academic medical center
Andrea K. Boggild a, Bret A. Nicks b, Leslianne Yen c, Wesley Van Voorhis c, Russell McMullen d,
Frederick S. Buckner c, W. Conrad Liles c,e,*
a Tropical Diseases Unit, Division of Infectious Diseases, University Health Network-Toronto General Hospital, Toronto, Ontario, Canada
bWake Forest University Baptist Medical Center, Winston-Salem, NC, USA
cDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA
dDivision of Emergency Medicine, University of Washington, Seattle, WA, USA
eDepartment of Medicine, Division of Infectious Diseases, University Health Network, University of Toronto,
Toronto General Hospital 13E 220, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada
A R T I C L E I N F O
Article history:
Received 21 July 2008
Received in revised form 11 May 2009
Accepted 27 May 2009
Corresponding Editor: William Cameron,
Ottawa, Canada
Keywords:
Antipsychotics
Delusional parasitosis
Laboratory specimens
Matchbox sign
Parasites
A B S T R A C T
Objectives: Delusional parasitosis is a syndrome with which most infectious diseases physicians and
microbiologists are familiar. However, little is known about the epidemiology of this disorder, and most
reports consist of case reports or small series. We conducted a case series with long-term questionnaire
follow-up of delusional parasitosis patients presenting to our academic medical center.
Methods: From 1994 through 1999, 23 patients with primary delusional parasitosis (as deﬁned by DSM
IV criteria) were identiﬁed through the Infectious Diseases Clinic or Emergency Room at the University of
Washington and cases were analyzed for prospectively established demographic, clinical, and social
variables of interest.
Results: Of 23 patients, 15 were women and eight were men. Mean duration ( standard deviation) of
symptoms was 2.6  2.8 years (median 1.5), with shorter duration related to improved prognosis. Mean
symptomduration inwomenwas 3.1  3.0 years versus 1.5  1.5 years inmen. Patients saw an average of six
physicians before presenting to our center. Reduced social interactions were common, but employment
affect was not signiﬁcant. Treatment with pimozide or gabapentin combined with antidepressants appeared
to be effective in some cases.
Conclusions: This is the largest study of primary delusional parasitosis originating from an academic
medical center, and highlights the burden of disease borne by patients and the healthcare system.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Delusional parasitosis (DP) is a delusional disorder character-
ized by a ﬁxed belief of infestation by parasites, despite a lack of
supporting medical evidence.1–3 DP patients fail to fulﬁll criteria
for schizophrenia, including disorganized speech, disorganized or
catatonic behavior, and negative symptoms such as avolition or
blunted affect. DP may involve tactile hallucinations, psychosocial
functioning may be variably impaired secondary to the delusion,
and the duration of any concurrent mood disorder must be brief in
comparison to the total duration of the delusion in order to meet
diagnostic criteria. Primary DP is not due to a general medical
condition or substance abuse, and it is this type of DP with which
the study reported herein is concerned.* Corresponding author. Tel.: +1 416 340 4800x3624; fax: +1 416 340 3357.
E-mail address: Conrad.liles@uhn.on.ca (W.C. Liles).
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doi:10.1016/j.ijid.2009.05.018DP has been reported worldwide and secondary to a variety of
medical disorders including stroke, leprosy, peripheral neuro-
pathy, and loss of visual acuity, as well as substance abuse and
other psychiatric disorders.4–6 This situation constitutes second-
ary DP, unlike primary DP which is not associated with other
illnesses. Patients who experience DP present primarily to
primary care physicians and dermatologists, and less frequently
are seen by psychiatrists, emergency room physicians and
infectious disease specialists.1 Trabert’s meta-analysis of 1223
case reports described a mean symptom duration of 3.0  4.6
years, with amale to female ratio of 1:2, decreasing to 1:3 in patients
aged 50 years. Several other case reports and retrospective
analyses have reported male-to-female ratios from 1:1.5 to 1:4.6–8
The prevalence of this disorder is unknown. Signs include bruising,
contact dermatitis, scratching, excoriation and licheniﬁcation
secondary to self-inﬂicted scratches or attempted cures with caustic
substances. Frequently cited and occurring in approximately 25% of
patients with DP is the so-called ‘matchbox sign’, which consists ofses. Published by Elsevier Ltd. All rights reserved.
Table 1
Demographic characteristics of 23 patients with
delusional parasitosis
Characteristic Number (percentage)
Gender
Male 8 (35)
Female 15 (65)
Age 46.6 years
(median 45,
range 31–77)
Ethnicity
Caucasian 18 (78)
African American 3 (13)
Asian 1 (4)
Hispanic 1 (4)
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offending organisms.2,9
The earliest and most frequently reported medication for the
treatment of DP is pimozide, an antipsychotic with successful
remission rates and associated incidence of extrapyramidal side
effects related to D2 receptor blockade.2,8,10,11 It is thought that
serotonergic receptors mediate sensations and perceptions that
contribute to delusional symptoms. Successful treatment of DP
with atypical antipsychotic medications, including amisulpride,
risperidone, olanzapine, and quetiapine, have been reported,2,10–12
though amisulpride, risperidone, and olanzapine are generally
regarded as ﬁrst-line agents.2 Excellent, comprehensive reviews of
the clinical efﬁcacy of antipsychotics in the management of both
primary and secondary DP are provided elsewhere.11,12
Limitations of previous studies include small sample size,
retrospective design, limited follow-up, and little information
about patient demographic backgrounds. Results of other series
are confounded by inclusion of patients with intercurrent general
medical or psychiatric conditions such as leprosy, dementia, and
major depression.7 We present a retrospective analysis of 23 cases
of isolated, primary DP presenting to the emergency room and
infectious disease physicians at an academic medical center, with
long-term questionnaire-based follow-up data on eight cases.
2. Methods
Approval was granted by the human subjects review committee
of the University of Washington to review patient records and
contact individuals for completion of a questionnaire prior to
initiation of the study.
All individuals with the diagnosis of DP evaluated in the
Infectious Diseases/Tropical Medicine Clinic and Emergency Room
between January 1994 and December 1999 were considered for
the study. Patient histories, physical examinations, demographic
data including race, sex, age, and symptomswere catalogued on all
individuals. All patients underwent the following testing before or
at the time of evaluation at the University of Washington:
complete blood count (CBC), liver function tests (LFTs), thyroid
function tests, blood urea nitrogen, creatinine and skin scrapings.
Selected patients underwent evaluation of stool for ova and
parasites (O&P). Some individual patients also underwent sigmoi-
doscopy, colonoscopy, chest X-ray, head computed tomography,
and brain magnetic resonance imaging as part of their evaluations.
A discharge diagnosis of DP had been assigned to 43 individuals.
Of these, 23 individualswere judged to have primaryDP, not related
to underlying psychosis, medical disorder, or substance use, based
onDSM-IV criteria. A questionnairewasmailed to the23 individuals
with primary DP. The questionnaire consisted of 27 questions to
address such issues as initial symptoms, initial and current severity,
duration of symptoms prior to initial care, duration of symptoms
prior to care at the University of Washington, number and type of
careproviders, diagnosis received, treatments receivedandbeneﬁts,
illness course, social effects, believed medical complications,
substance use, demographics and perception of care received
related toDP.Variantswithin thedisorder (folie a` deux, projectionof
the disorder onto children, etc.) and effects on lifestyle were also
addressed. Threeweeks after the initialmailing, reminder postcards
were sent tomaximize returnofquestionnaires.Data are reportedas
means standard deviation.
3. Results
3.1. Demographic characteristics
Females outnumbered males by a ratio of 1.9:1 (15:8). Mean
age at ﬁrst examination was 46.6  11.3 years. Male patients were,on average, almost 11 years younger than females (39.5  7.0 vs.
50.3  11.5). Patients were predominantly Caucasian (78%), with
African-American (13%), Asian (4%), and Hispanic representations
(4%) (Table 1).
Educational backgroundwas varied and ranged from some high
school education to completion of a professional degree, with a
mean level of education equivalent to some college training. In
addition, only 26% of all patients were currently unemployed, with
half of these stating their jobs were terminated or they had to quit
due to their illness. The remaining 74% continued to function in the
workplace, or had retired from working altogether. The overall
impact on functional employment seemed to be limited, as most
patients with DP were able to maintain current employment
status.
3.2. Perceived infecting agents
Many patients described cutaneous symptoms as the ﬁrst
evidence of infestation. Tactile and visual hallucinations of
parasitic movement and activities were described in 39% of
patients. Pruritus affected 44% of patients, and 35% brought in
samples of the alleged parasites enclosed in various small
containers, paper tissues, and plastic bags (Figure 1). Eight patients
(35%) presentedwith skin lesions, most commonly located in areas
reachable by the patient. Mild fever, fatigue, nausea, burning and
non-speciﬁc pain were also described in addition to the skin
lesions. Worm infestation and non-speciﬁc parasites/bugs were
the two most common perceived causes of illness (Table 2).
3.3. Presentation and care providers
Patients sought initial care after an average of 8.4  12.0 weeks
of symptoms. In a majority of the cases, a family practice physician
provided the initial care. Self-referral to the University ofWashington
for care was initiated at 93.6  150.6weeks, often after seeing several
physicians outside the University system. Throughout the course of
the patient’s work-up, 6.3  3.5 providers were seen for evaluation of
the symptoms. This included infectious disease specialists, emer-
gency physicians, dermatologists, naturopaths, and family physi-
cians. There was generally not a history of international travel or
exposures that would have put persons at risk for parasitic infection
or infestations.
3.4. Diagnostic test results
No signiﬁcant abnormalities to account for the symptoms were
noted on investigations including CBC, LFTs, skin scrapings, stool
O&P examinations, or diagnostic imaging. Two patients carried a
previous diagnosis of parasitic infections, including pinworms and
Figure 1. Representative specimens from patients with delusional parasitosis sent to the laboratory for microbiologic examination: (A) urine collection container containing
dust and lint; (B) urine collection container containing a garden grub; (C) paint sponge with exfoliated skin cells; (D) specimen from urine collection container containing
organic plant matter, hair, and carpet ﬁbers; (E) toenail clipping sent as a ‘worm’; (F) multiple specimens from a patient organized according to source.
Table 2
Perceived cause of illness among 23 patients with delusional
parasitosis
Perceived cause Number (percentage)
Worm infestation 10 (44)
Non-speciﬁc parasite or bug 8 (35)
Skin puncture inoculation 2 (9)
Lice 1 (4)
Table 3
Social impact of disease on eight patients with delusional
parasitosis from follow-up survey
Social impact Number (percentage)
Personal life
No effect 1 (12.5)
Moderate effect 5 (62.5)
Major effect 2 (25)
Employment
No effect 3 (37.5)
Moderate effect 1 (12.5)
Job loss 2 (25)
Unemployed 2 (25)
Household members affected
Yes 5 (62.5)
No 3 (37.5)
Perception of contagion
Yes 5 (62.5)
No 3 (37.5)
Reduced contact
With family 4 (50)
With acquaintances 6 (75)
Substance use/abuse
Alcohol 2 (25)
Sedatives 3 (37.5)
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evidence of these infestations at the time of evaluation at the
University of Washington Medical Center. Previous diagnoses
given to the patients in this study by other healthcare providers
included probable parasitic infection, digestive disorders, clinical
depression, pinworms, yeast infection, lice, scabies, hypochon-
driasis, impetigo and chronic fatigue syndrome.
3.5. Follow-up questionnaire data
The response rate to the questionnaire was 35%. Analysis of
questionnaires from respondents with DP (n = 8) revealed a mean
duration of symptoms (calculated as time from onset of initial
symptoms to last point of follow-up) of 2.6  2.8 years (median 1.5
years). The mean duration of symptoms in females was twice that of
males, 3.1  3.0 years vs. 1.5  1.5 years.
Symptom severity was graded from 1 to 5, with 5 representing
extremely severe symptoms and 1 representing mild symptoms.
The mean initial severity of symptoms was rated 3.5  1.5. At
follow-up, mean severity was 3.0  1.9 with subjective improvement
noted in ﬁve of eight patients. Patients with full recovery or
symptoms described as mild had a shorter duration than patients
with an incomplete or absent remission (1.2  0.8 vs. 3.0  1.5 years).3.6. Social impact
Data on social ramiﬁcations of DP, including personal, employ-
ment, household, and substance use information, were available
for eight patients who completed the follow-up questionnaire
(Table 3). Only one of the patients stated his personal life was
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because of their illness. Contagiousness was a concern in ﬁve of the
patients, which may account for the four who claimed to decrease
contacts with family members and six who intentionally reduced
contact with non-family. Two patients reported alcohol use. One
patient reported consumption of 1–2 drinks/day and the other
drank daily to the point of inebriation. Intravenous drug abuse
history was noted in one of the eight cases, with this patient
abstaining for 2 years prior to the index examination. Sedatives
were utilized by three of the patients to treat insomnia (Table 3).
3.7. Perception of illness and care given
Five patients completing the follow-up questionnaire (63%)
considered themedical care rendered by all providers related to DP
as ‘poor’, while only 25% rated it as ‘very good’. Most cited ‘lack of
understanding’ as the primary cause for dissatisfaction. Despite
their difﬁcult course, 63% believed there was a cure for their
‘physical illness’.
3.8. Treatments given and effectiveness
Most patients in the study were discouraged by the absence of
evidence supporting parasitic infection and any suggestion of
psychological etiology and refused any psychopharmacologic
therapy. Of the 23 patients with a diagnosis of primary DP, only
four accepted referral to psychiatry as part of their treatment
protocol. Of the three follow-up patients reporting complete
remission or very mild residual symptoms, two had been treated
with standard doses of gabapentin and the third had been treated
with pimozide (1–12 mg/day). Two additional patients on
pimozide were lost to follow-up. Five of 23 patients were started
on antidepressantmedications. Of those, several reported dramatic
improvement of symptom severity with anti-depressant therapy
when combined with a low dose high potency antipsychotic
medication such as olanzapine.
4. Discussion
Patients with DP suffer from the physical and psychological
discomfort of their delusions as well as the sequelae of self-
inﬂicted, often injurious treatments.13,14 This study highlights the
social impact of DP, revealing affected personal life in 87%,
decreased employment in 63%, disrupted households in 63%, and
reduced social contacts both within the home andwith non-family
members. The ethnicity of this patient population reﬂects the
ethnic distribution of Seattle, supporting other reports that DP is a
condition which crosses social and cultural boundaries. The mean
duration of symptoms in our patient population was shorter than
that reported in other studies, perhaps due to a bias in the way we
determined duration of symptoms as ending with last interven-
tion. Similar to the results of other studies, follow-up was
accomplished in only the minority of our patients.1,15,16
Like any delusional disorder, DP is a difﬁcult and costly
illness to manage. Specialist referrals, ‘doctor shopping’ due to
patient dissatisfaction, and utilization of laboratory and
diagnostic services all culminate in a signiﬁcant economic
burden for non-state controlled healthcare systems to absorb.
The true extent of this burden remains unknown due to a lack of
prevalence data. In our series, patients saw an average of six
healthcare providers before presentation to our academic
medical center, and underwent countless diagnostic tests
including medical imaging over the course of their protracted
work-up. Gatekeeping on the part of the clinician is difﬁcult due
to the persistent conviction on the part of the patient that they
are truly afﬂicted with a medical condition, and the need for athorough initial work-up, which may, in fact, be ordered
multiple times by multiple different physicians, unbeknownst
to each. This phenomenon can be exceedingly frustrating for the
microbiology and parasitology laboratories, which are obligated
to ‘test’ whatever specimens are received. Enforcement of strict
specimen appropriateness criteria on the part of the laboratory
can alleviate some of the burden of unnecessary testing. For
instance, paper towels, sponges, and linens are inappropriate
specimens for the diagnosis of scabies, whereas a properly
collected skin scraping is indicated.
‘Costs’ to the patient are also enormous. Real suffering
engendered by the belief in their medical illness, lack of validation
by the medical community, absences from work, self-imposed
limitations on social interaction, family disruptions, toxic and
caustic ‘remedies’, substance abuse, and self-ﬁnanced diagnostic
evaluations all contribute to the immense personal costs borne by
these patients. Almost two-thirds of respondents to the follow-up
questionnaire suffered negative consequences related to employ-
ment, including job loss. Fears of contagion which limit patients’
social interactions should be approached with continued reassur-
ances on the part of the clinician. Where possible, family and
friends can be enlisted for support and should be educated on the
non-infectious nature of DP. Empathy and patience are important
to exercise when assessing those suffering from DP.
DP is a disorder with which every microbiologist, infectious
diseases/tropical medicine specialist, dermatologist, and emer-
gency medicine personnel becomes familiar. To date, however,
the only effective pharmacologic options are antipsychotic
medications.2,10–12,17,18 The indications, dosing, adjustment, side
effects, and adverse events associated with psychotropic medica-
tions is beyond the scope of infectious diseases/tropical medicine
practice. Serious adverse events including extrapyramidal symp-
toms and QTc prolongation can occur with antipsychotic
drugs.2,10,17,18 Thus, DP is best managed by psychiatrists or other
physicians who are accustomed to prescribing and managing
compliance with these medications.13 Referral of DP patients to
psychiatry presents its ownset of challenges.2,10 In our series, only
17%of patients accepted such a referral, and this level of resistance
to psychiatric care is common.2,10,13,14,17,18 Thus, strategies that
encourage the uptake of referrals to physicians with specialized
training in the management of primary delusional disorders
would be beneﬁcial.
This study is limited by its retrospective design, poor response
to the follow-up questionnaire (35% response rate) creating a
potential selection bias, and potential lack of external validity. In
addition, the small sample size prevents us from drawing any
conclusions about therapeutic efﬁcacy in this series.
In summary, DP is one of the more challenging entities that
infectious diseases specialists will be enlisted to help treat.
Unfortunately, optimal therapeutic regimens leading to sustained
remission are lacking, and assurances on the part of the clinician do
little to ameliorate patient suffering. Our series, the largest to date
reported from a single academic medical center, underscores the
personal burden borne by those afﬂicted with primary DP, and the
extent of service utilization within the healthcare community
throughout the course of evaluation. Evidence of effective
strategies to better manage these patients and to contain costs
associated with redundant and unnecessary work-up is sorely
needed.
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